biotech · Blepharitis · Meibomian Gland Dysfunction · TARS
Tarsus Pharmaceuticals
Tarsus Pharmaceuticals trial registry — 14 ClinicalTrials.gov studies with program phase, status, and indication context.
15440 Laguna Canyon Rd, Irvine, California 92618, US HQ
2017 Founded
403 Employees
Public company Type
TARS · NYSE Ticker
Company details
- Status
- Public
- HQ
- 15440 Laguna Canyon Rd, Irvine, California 92618, US
- Founded
- 2017
- Employees
- 403
- Programs
- 14
- Drugs
- 10
- Patents
- 9
Tarsus Pharmaceuticals clinical trials
Registry index of 14 ClinicalTrials.gov studies linked to Tarsus Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.
Tarsus Pharmaceuticals trial registry — 14 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Tarsus Pharmaceuticals.
-
TP-05 (lotilaner oral), fasted group — Phase 1
Clinical update -
TP-05 (lotilaner oral capsules) — Phase 1
Clinical update -
TP-05 (lotilaner) Low Dose — Phase 2
Clinical update -
TP-03 (Lotilaner Ophthalmic Solution), 0.25% — Phase 1
Clinical update -
Low Dose TP-05 — Phase 2
Clinical update -
Lotilaner ophthalmic solution, 0.25% — Approved
Clinical update -
Uteratonic administration — Unknown
Clinical update -
Standart medical treatment — Unknown
Clinical update